GARDP 212d ago

👶 Every year, 3 million newborns are affected by sepsis — one of the leading causes of death in this vulnerable age group. To mark World Children’s Day, Carol Ruffell shares how GARDP is responding through NeoSep1 trial, a groundbreaking global clinical trial evaluating new antibiotic combinations specifically for newborns in hospitals across Africa and Asia, where the burden is highest. Every newborn deserves a fair chance at life. By advancing treatment for neonatal sepsis, we can secure healthier futures for children worldwide. 🔗 Read more in GARDP’s paediatric policy paper: https://gardp.org/neonatal-sepsis/ #WorldChildrensDay #NeonatalSepsis #GlobalHealth #Antibiotics #GARDP